Gül Erdemli

Company: Novartis AG

Job title: Global Program Regulatory Director

Seminars:

Developing Novel Digital Measures for Neurodegenerative Diseases 11:30 am

Incorporating functional and mobility performance assessments in Alzheimer’s and Parkinson’s populations Highlighting the potential of digital measures to capture patient experiences in real-world settings Outlining feedback from regulatory agencies about how these endpoints can be further developedRead more

day: Conference Day One - Track Three